Peer-reviewed veterinary case report
Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors.
- Journal:
- Cells
- Year:
- 2022
- Authors:
- de Nardi, Andrigo Barboza et al.
- Affiliation:
- Department of Veterinary Clinic and Surgery · Brazil
- Species:
- dog
Plain-English summary
Mast cell tumors are a type of cancer that affects dogs, specifically involving cells called mast cells that are part of the immune system. These tumors are the most common malignant skin tumors in dogs, making up about 11% of all skin cancer cases. A recent meeting focused on the latest findings regarding how to diagnose, predict outcomes, and treat these tumors in dogs. This information is important for veterinarians to provide the best care for dogs diagnosed with mast cell tumors.
Abstract
Mast cell tumors (MCTs) are hematopoietic neoplasms composed of mast cells. It is highly common in dogs and is extremely important in the veterinary oncology field. It represents the third most common tumor subtype, and is the most common malignant skin tumor in dogs, corresponding to 11% of skin cancer cases. The objective of this critical review was to present the report of the 2nd Consensus meeting on the Diagnosis, Prognosis, and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors, which was organized by the Brazilian Association of Veterinary Oncology (ABROVET) in August 2021. The most recent information on cutaneous and subcutaneous mast cell tumors in dogs is presented and discussed.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/35203268/